CTLA4 and hypophysitis: Clinically, most cases may be classified in three different nosocomial entities: hypophysitis, mostly associated with anti-CTLA4 antibodies, thyroid dysfunction, more related to anti-PD1 CPIs and insulin-deficient diabetes mellitus.